The FDA is having PAR redo the dosing. A tremendous amount of time and money was wasted on the previous trial! Also, no mention of DMOD in the new study...PAR is obviously moving away from that claim.
Where we at?, page-268
-
- There are more pages in this discussion • 439 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
0.005(2.22%) |
Mkt cap ! $81.36M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 24.0¢ | 22.5¢ | $132.4K | 570.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 26000 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 63529 | 6 |
View Market Depth
| Last trade - 14.10pm 13/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |